SRPT FY 2021 Earnings — Sarepta Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

SRPTSarepta Therapeutics, Inc.

$2B

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$702M+30.0% YoY

Gross Profit

$605M86.2% margin

Operating Income

-$460M-65.5% margin

Net Income

-$419M-59.7% margin

EPS (Diluted)

$-5.15

Cash Flow

Operating Cash Flow

-$443M

Free Cash Flow

-$482M

Stock-Based Comp.

$114M

Balance Sheet

Total Assets

$3.1B

Total Liabilities

$2.2B

Stockholders' Equity

$928M

Cash & Equivalents

$2.1B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$702M	$540M	+30.0%
Gross Profit	$605M	$477M	+26.9%
Operating Income	-$460M	-$564M	+18.5%
Net Income	-$419M	-$554M	+24.4%